China International Medicinal Equipment Fair (CMEF)
view counter

Medical Device Industry News

FDA panel narrowly clears Medtronic DBS device

March 15, 2010 by MassDevice staff

A special panel convened by the Food & Drug Administration narrowly cleared Medtronic's Activa DBS deep-brain stimulation device for treating epilepsy, despite concerns over its efficacy and safety.

MDT logo

By Thomas Lee

A Food & Drug Administration panel narrowly approved a deep brain stimulation device developed by Medtronic Inc. (NYSE:MDT) to treat epilepsy.

The panel voted 7-5 to green-light the Activa DBS, which uses electricity to stimulate the anterior nucleus region of the brain. The panel’s findings are not binding on the FDA, but the agency almost always follows the recommendations of such bodies.

Caliper settles 14-month patent spat with Shimazdu

March 15, 2010 by MassDevice staff

Hopkinton, Mass.-based lab equipment and services provider Caliper Life Sciences reaches a settlement with Shimadzu Scientific Instruments Inc. over its electrophoresis system.

Caliper Life Sciences, Inc. (Nasdaq: CALP) says that Shimazdu Scientific Instruments, Inc. has agreed to remove one of its DNA and RNA sequencers from the U.S. market after the company's settled a 14-month patent dispute.

The Hopkinton, Mass.-based lab equipment and services provider had alleged that Shimazu's MCE-202 MultiNA microchip electrophoresis system infringed on 11 different U.S. patents held by Caliper. The MultiNA is a microchip electrophoresis system the company says can quickly and easily perform DNA and RNA nucleic acid size confirmation and quantitation in life science research.

Boston Scientific holds ICD, CRT shipments on FDA snafu

March 15, 2010 by MassDevice staff

Boston Scientific Corp.'s stock dips on news that it's holding all shipment of its implantable cardiac defibrillators and cardiac resynchronization therapy devices, after discovering it missed filings with the Food & Drug Administration.

BSX logo

Boston Scientific Corp. (NYSE:BSX) is holding all shipments of its implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators and pulling all inventory from the field after discovering that it missed a pair of filings with the Food & Drug Administration.

The medical device-making giant said it failed to notify the FDA of two changes to its manufacturing process for its Cognis, Confient, Livian, Prizm, Renewal, Teligen and Vitality ICDs and CRT-Ds. The changes were "successfully validated" and there is no risk to patient safety, according to a press release. Boston Scientific's pacemakers and other products are not affected by the move.

Medtronic launches clinical trial of CoreValve heart valve replacement system

March 12, 2010 by MedCity News

Medtronic Inc. launches a 1,000-patient study of its CoreValve aortic stenosis therapy, designed as a minimally invasive method of replacing faulty heart valves.

MedCity News

By Brandon Glenn

Medtronic Inc. (NYSE:MDT) launched what’s expected to be a 1,000-patient study of a catheter-based system it hopes will become a less-invasive — and highly lucrative — alternative to open-heart surgery for valve replacement.

Medtronic’s CoreValve system allows a replacement heart valve to be placed in a patient’s body via a catheter inserted in the femoral artery, near the groin. A catheter is a thin, flexible tube that can be inserted into a body cavity to open a passageway or to allow fluids to pass through.

OMNIlife inks distribution deal with French artificial hip maker

March 12, 2010 by MassDevice staff

Taunton, Mass.-based OMNIlife Science Inc. will be the exclusive distributor of hip articulation technology made by Societe d'Etudes Recherches Fabrication-Dedienne Sante.

OMNIlife logo

OMNIlife Science Inc. will be the exclusive U.S. distributor of articulation technology used in artificial hips made by a French maker of orthopedic and dental implants.

Taunton, Mass.-based OMNIlife said the deal with Societe d'Etudes Recherches Fabrication-Dedienne Sante will begin as soon as the company receives regulatory approval from the Food & Drug Administration. Further terms of the deal were not announced.

FDA warns on fake surgical mesh

March 12, 2010 by MassDevice staff

The Food & Drug Administration issues a warning to healthcare providers about counterfeit surgical mesh products that ape C.R. Bard's Davol brand.

FDA logo

The Food & Drug Administration is warning healthcare providers to be on the lookout for fake surgical mesh products that ape C.R. Bard's (NYSE:BCR) Davol Inc. brand, saying hospitals and surgical centers — not to mention patients with surgical mesh implants — should be especially vigilant.

The federal watchdog agency said four sizes of the counterfeit flat sheet polypropylene surgical mesh have been pegged by the FDA and Bard so far:

Medtronic registers $3 billion debt offering

March 12, 2010 by MassDevice staff

Minneapolis-based medical device monolith Medtronic registers for a $3 billion offering of its senior debt notes to drum up cash for working capital and perhaps to pay down debt.

MDT logo

Medtronic Inc. (NYSE:MDT) registered with the Securities & Exchange Commission for a $3 billion offering of senior debt notes in a bid to raise funds to cover its working capital needs and, perhaps, to pay down some of its debt.

The Fridley, Minn.-based medical device monolith announced the offering of $1.25 billion worth of its 3 percent senior notes, due in 2015; $1.25 billion of its 4.45 percent senior notes due in 2020; and $500 million of its 5.55 percent senior notes due in 2040.

browse jobs and career opportunities in the medical devices industry
view counter
Instron manufactures tensile, compression, fatigue, impact and hardness testing machines, testing a variety of  materials and ra
view counter

NEWS

NxStage locks in $15 million credit line from Silicon Valley Bank

Lawrence, Mass.-based portable dialysis maker NxStage Medical Inc. says the deal gives it some...

NMT names eight to advisory board

Boston, Mass.-based NMT Medical beefs up its science chops as it prepares for Closure 1 trial data...

Breeden's Robert Fields quietly steps down from Steris board

Robert Fields, partner and managing director at Breeden Capital Management and Breeden Partners,...

Harvard Bioscience jumps into the regenerative medicine market

Holliston, Mass.-based scientific instrument maker Harvard Bioscience launches a bioreactor as it...

UPDATE: Fluidnet's CEO on its $9 million funding round

Portsmouth, N.H.-based IV infusion system developer Fluidnet Corp. drums up $9 million in an equity...

SEARCH JOBS


Search our database for the best open jobs in the medical devices industry.

keywords

job title or skills
location

city, state or zip

Jobs by MassDevice

The massPLASTICS Medical Device Connection is your portal to more than 35 innovative plastics companies
view counter
16th MDMA Annual Meeting - May 24-26, 2010 - Register Today
view counter
Test with certainty, Test with ADMET
view counter
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp